Cargando…
Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Lessons learned from cardiology: the process for approval of medical therapeutic devices must be redesigned http://ow.ly/bJPm3017ySH
Autor principal: | Frigerio, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487206/ https://www.ncbi.nlm.nih.gov/pubmed/27581821 http://dx.doi.org/10.1183/16000617.0037-2016 |
Ejemplares similares
-
OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form
por: Fudin, Jeffrey, et al.
Publicado: (2016) -
Synchrony 2022: Roundtable Discussion on the Pathways and the Challenges of Getting Medications FDA Approved
por: Belfort, Gabriel, et al.
Publicado: (2023) -
Covert medication: Do means justify the ends?
por: Rao, T. S. Sathyanarayana, et al.
Publicado: (2012) -
Justifiable Scope of Medical Journal Advertising
por: Bogart, G. Henri
Publicado: (1915) -
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2019
por: Rameau, Anais, et al.
Publicado: (2020)